Navigating the MDR jungle<\/h1><\/div><\/div><\/div><\/div><\/div><\/div>Key Insights for Medical Software Development<\/h2><\/div>The European Medical Device Regulation (MDR) <\/a>is a complex landscape with many regulations and hidden challenges. We have navigated this terrain successfully and help manufacturers develop innovative, compliant medical software solutions. <\/p>\nThanks to our many years of experience with software solutions for regulated environments\u2014including BAYOOSOFT Access Manager<\/a> for the compliant management of access rights and BAYOOSOFT Themis<\/a> for structured compliance and risk management\u2014 we have hands-on experience with the requirements of the MDR environment and understand what matters most when developing and operating certifiable software.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>The challenges under MDR<\/h2><\/h2><\/div>Developing medical software under the MDR is like trekking through a dense rainforest\u2014full of obstacles, but also full of opportunities for those equipped with the right tools. Below, you\u2019ll learn how we\u2019ve learned to overcome the biggest challenges: <\/p>\n<\/div><\/div><\/div>
<\/i><\/div><\/div>UDI System and QMS Integration<\/strong>
\nImplementing a UDI (Unique Device Identification) system is not just a matter of regulatory compliance; it must be seamlessly integrated into the quality management system (QMS) and, ideally, into the development pipeline as well. This integration minimizes manual effort and ensures consistency. <\/p>\n<\/div><\/div><\/div><\/div><\/div>Unannounced Audits
\n<\/strong>Preparing for unannounced audits is essential. Establish standard operating procedures (SOPs) that describe how you should respond in such situations: Ensure a pleasant environment, offer refreshments, and immediately gather your experts to answer the auditors\u2019 questions. This preparation will help you remain calm and efficient during the audits. <\/p>\n<\/div><\/div><\/div><\/i><\/div><\/div><\/div><\/div><\/i><\/div><\/div>Clinical Evaluation
\n<\/strong>Clinical evaluations under the MDR require verifiable safety and performance endpoints, which are difficult to substantiate retrospectively. Establishing equivalence\u2014particularly for software\u2014often requires deep insight into the core algorithm. Be prepared for a thorough review if you choose this path. <\/p>\nIt\u2019s insufficient to rely solely on a single scientific database. Utilize diverse scientific publication databases to ensure comprehensive coverage and avoid overlooking critical studies. <\/p>\n<\/div><\/div><\/div><\/div><\/div>
Cybersecurity measures
\n<\/strong> Auditors expect state-of-the-art cybersecurity measures, including vulnerability scans and penetration tests, even if these are not explicitly required. It is advisable to implement these measures proactively. <\/p>\nGuidance Document MDCG 2019-16 rev.1 provides a framework that emphasizes the traditional risk management cycle: plan, analyze, evaluate, and mitigate. In addition, the FDA guidelines offer more detailed examples and can serve as valuable supplements. <\/p>\n
The level of detail in an inspection depends on the inspector\u2019s expertise. If the inspection focuses on cybersecurity, you should be prepared for detailed discussions about risk assessments. We have found that the use of the Common Vulnerability Scoring System (CVSS) has been satisfactory for auditors so far. <\/p>\n<\/div><\/div><\/div>
<\/i><\/div><\/div><\/div><\/div><\/i><\/div><\/div>Usability and Risk Management
\n<\/strong>Usability studies and risk management are of central importance for MDR compliance, even though usability is mentioned in the MDR only in connection with post-market surveillance (PMS). Auditors are increasingly focusing on documentation and traceability and require that all measures\u2014even best practices\u2014be explicitly documented. Keep the original records from your suppliers, as they may be requested during future inspections. <\/p>\nThis iterative process extends over the entire product life cycle. A one-page summary of tests carried out with a small group is insufficient; comprehensive documentation is required. <\/p>\n<\/div><\/div><\/div><\/div><\/div>
Post-Market Surveillance
\n<\/strong>For software, post-market surveillance involves collecting data from support channels, monitoring the Software Bill of Materials (SBOM), reviewing crash reports, and conducting compatibility tests with new operating systems or devices. Changes to SOUP (Software of Unknown Provenance) components or the underlying operating systems occur frequently and require constant vigilance. The more your product gains prominence in the market, the more feedback you can expect, which requires thorough documentation and analysis. <\/p>\nTrend analyses and effective data collection methods are essential for preparing the Periodic Safety Update Report (PSUR) and maintaining compliance. Selecting the right statistical methods is crucial. Recommended methods include Weibull analysis (as recommended in ISO 24971), the Nelson rules (as recommended in ISO\/TR 20416), the Mann-Kendall test, or the Neumann trend test (for normally distributed populations). <\/p>\n<\/div><\/div><\/div>
<\/i><\/div><\/div><\/div><\/div>Survival tips for the MDR landscape<\/h2><\/h2><\/div>- <\/i><\/span>\n
Start small, iterate quickly<\/span>
\n<\/strong>Start with a Minimum Viable Product (MVP) to test usability and user acceptance. This approach helps control risks and accelerate progress. <\/p>\n<\/div><\/li>- <\/i><\/span>\n
Incorporating Agile Compliance<\/span>
\n<\/strong>By integrating compliance into agile development cycles, your process remains adaptable while staying in line with MDR requirements.<\/p>\n<\/div><\/li>- <\/i><\/span>\n
Documentation is essential, but keep it concise<\/span>
\n<\/strong>Think of documentation as your bike. It records every step and ensures you have evidence to present when auditors inquire about your process. <\/p>\n<\/div><\/li>- <\/i><\/span>\n
Collaborate Early and Often<\/span>
\n<\/strong>Involve the Notified Bodies, cybersecurity experts, and other stakeholders early on to effectively manage the complexity.<\/p>\n<\/div><\/li><\/ul><\/div><\/div><\/div><\/div>
Key Insights for Medical Software Development<\/h2><\/div>The European Medical Device Regulation (MDR) <\/a>is a complex landscape with many regulations and hidden challenges. We have navigated this terrain successfully and help manufacturers develop innovative, compliant medical software solutions. <\/p>\nThanks to our many years of experience with software solutions for regulated environments\u2014including BAYOOSOFT Access Manager<\/a> for the compliant management of access rights and BAYOOSOFT Themis<\/a> for structured compliance and risk management\u2014 we have hands-on experience with the requirements of the MDR environment and understand what matters most when developing and operating certifiable software.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>The challenges under MDR<\/h2><\/h2><\/div>Developing medical software under the MDR is like trekking through a dense rainforest\u2014full of obstacles, but also full of opportunities for those equipped with the right tools. Below, you\u2019ll learn how we\u2019ve learned to overcome the biggest challenges: <\/p>\n<\/div><\/div><\/div>
<\/i><\/div><\/div>UDI System and QMS Integration<\/strong>
\nImplementing a UDI (Unique Device Identification) system is not just a matter of regulatory compliance; it must be seamlessly integrated into the quality management system (QMS) and, ideally, into the development pipeline as well. This integration minimizes manual effort and ensures consistency. <\/p>\n<\/div><\/div><\/div><\/div><\/div>Unannounced Audits
\n<\/strong>Preparing for unannounced audits is essential. Establish standard operating procedures (SOPs) that describe how you should respond in such situations: Ensure a pleasant environment, offer refreshments, and immediately gather your experts to answer the auditors\u2019 questions. This preparation will help you remain calm and efficient during the audits. <\/p>\n<\/div><\/div><\/div><\/i><\/div><\/div><\/div><\/div><\/i><\/div><\/div>Clinical Evaluation
\n<\/strong>Clinical evaluations under the MDR require verifiable safety and performance endpoints, which are difficult to substantiate retrospectively. Establishing equivalence\u2014particularly for software\u2014often requires deep insight into the core algorithm. Be prepared for a thorough review if you choose this path. <\/p>\nIt\u2019s insufficient to rely solely on a single scientific database. Utilize diverse scientific publication databases to ensure comprehensive coverage and avoid overlooking critical studies. <\/p>\n<\/div><\/div><\/div><\/div><\/div>
Cybersecurity measures
\n<\/strong> Auditors expect state-of-the-art cybersecurity measures, including vulnerability scans and penetration tests, even if these are not explicitly required. It is advisable to implement these measures proactively. <\/p>\nGuidance Document MDCG 2019-16 rev.1 provides a framework that emphasizes the traditional risk management cycle: plan, analyze, evaluate, and mitigate. In addition, the FDA guidelines offer more detailed examples and can serve as valuable supplements. <\/p>\n
The level of detail in an inspection depends on the inspector\u2019s expertise. If the inspection focuses on cybersecurity, you should be prepared for detailed discussions about risk assessments. We have found that the use of the Common Vulnerability Scoring System (CVSS) has been satisfactory for auditors so far. <\/p>\n<\/div><\/div><\/div>
<\/i><\/div><\/div><\/div><\/div><\/i><\/div><\/div>Usability and Risk Management
\n<\/strong>Usability studies and risk management are of central importance for MDR compliance, even though usability is mentioned in the MDR only in connection with post-market surveillance (PMS). Auditors are increasingly focusing on documentation and traceability and require that all measures\u2014even best practices\u2014be explicitly documented. Keep the original records from your suppliers, as they may be requested during future inspections. <\/p>\nThis iterative process extends over the entire product life cycle. A one-page summary of tests carried out with a small group is insufficient; comprehensive documentation is required. <\/p>\n<\/div><\/div><\/div><\/div><\/div>
Post-Market Surveillance
\n<\/strong>For software, post-market surveillance involves collecting data from support channels, monitoring the Software Bill of Materials (SBOM), reviewing crash reports, and conducting compatibility tests with new operating systems or devices. Changes to SOUP (Software of Unknown Provenance) components or the underlying operating systems occur frequently and require constant vigilance. The more your product gains prominence in the market, the more feedback you can expect, which requires thorough documentation and analysis. <\/p>\nTrend analyses and effective data collection methods are essential for preparing the Periodic Safety Update Report (PSUR) and maintaining compliance. Selecting the right statistical methods is crucial. Recommended methods include Weibull analysis (as recommended in ISO 24971), the Nelson rules (as recommended in ISO\/TR 20416), the Mann-Kendall test, or the Neumann trend test (for normally distributed populations). <\/p>\n<\/div><\/div><\/div>
<\/i><\/div><\/div><\/div><\/div>Survival tips for the MDR landscape<\/h2><\/h2><\/div>- <\/i><\/span>\n
Start small, iterate quickly<\/span>
\n<\/strong>Start with a Minimum Viable Product (MVP) to test usability and user acceptance. This approach helps control risks and accelerate progress. <\/p>\n<\/div><\/li>- <\/i><\/span>\n
Incorporating Agile Compliance<\/span>
\n<\/strong>By integrating compliance into agile development cycles, your process remains adaptable while staying in line with MDR requirements.<\/p>\n<\/div><\/li>- <\/i><\/span>\n
Documentation is essential, but keep it concise<\/span>
\n<\/strong>Think of documentation as your bike. It records every step and ensures you have evidence to present when auditors inquire about your process. <\/p>\n<\/div><\/li>- <\/i><\/span>\n
Collaborate Early and Often<\/span>
\n<\/strong>Involve the Notified Bodies, cybersecurity experts, and other stakeholders early on to effectively manage the complexity.<\/p>\n<\/div><\/li><\/ul><\/div><\/div><\/div><\/div>
The European Medical Device Regulation (MDR) <\/a>is a complex landscape with many regulations and hidden challenges. We have navigated this terrain successfully and help manufacturers develop innovative, compliant medical software solutions. <\/p>\n Thanks to our many years of experience with software solutions for regulated environments\u2014including BAYOOSOFT Access Manager<\/a> for the compliant management of access rights and BAYOOSOFT Themis<\/a> for structured compliance and risk management\u2014 we have hands-on experience with the requirements of the MDR environment and understand what matters most when developing and operating certifiable software.<\/p>\n<\/div><\/div><\/div> Developing medical software under the MDR is like trekking through a dense rainforest\u2014full of obstacles, but also full of opportunities for those equipped with the right tools. Below, you\u2019ll learn how we\u2019ve learned to overcome the biggest challenges: <\/p>\n<\/div><\/div><\/div> UDI System and QMS Integration<\/strong> Unannounced Audits Clinical Evaluation It\u2019s insufficient to rely solely on a single scientific database. Utilize diverse scientific publication databases to ensure comprehensive coverage and avoid overlooking critical studies. <\/p>\n<\/div><\/div><\/div><\/div><\/div> Cybersecurity measures Guidance Document MDCG 2019-16 rev.1 provides a framework that emphasizes the traditional risk management cycle: plan, analyze, evaluate, and mitigate. In addition, the FDA guidelines offer more detailed examples and can serve as valuable supplements. <\/p>\n The level of detail in an inspection depends on the inspector\u2019s expertise. If the inspection focuses on cybersecurity, you should be prepared for detailed discussions about risk assessments. We have found that the use of the Common Vulnerability Scoring System (CVSS) has been satisfactory for auditors so far. <\/p>\n<\/div><\/div><\/div> Usability and Risk Management This iterative process extends over the entire product life cycle. A one-page summary of tests carried out with a small group is insufficient; comprehensive documentation is required. <\/p>\n<\/div><\/div><\/div><\/div><\/div> Post-Market Surveillance Trend analyses and effective data collection methods are essential for preparing the Periodic Safety Update Report (PSUR) and maintaining compliance. Selecting the right statistical methods is crucial. Recommended methods include Weibull analysis (as recommended in ISO 24971), the Nelson rules (as recommended in ISO\/TR 20416), the Mann-Kendall test, or the Neumann trend test (for normally distributed populations). <\/p>\n<\/div><\/div><\/div> Start small, iterate quickly<\/span> Incorporating Agile Compliance<\/span> Documentation is essential, but keep it concise<\/span> Collaborate Early and Often<\/span>The challenges under MDR<\/h2><\/h2><\/div>
\nImplementing a UDI (Unique Device Identification) system is not just a matter of regulatory compliance; it must be seamlessly integrated into the quality management system (QMS) and, ideally, into the development pipeline as well. This integration minimizes manual effort and ensures consistency. <\/p>\n<\/div><\/div><\/div><\/div><\/div>
\n<\/strong>Preparing for unannounced audits is essential. Establish standard operating procedures (SOPs) that describe how you should respond in such situations: Ensure a pleasant environment, offer refreshments, and immediately gather your experts to answer the auditors\u2019 questions. This preparation will help you remain calm and efficient during the audits. <\/p>\n<\/div><\/div><\/div>
\n<\/strong>Clinical evaluations under the MDR require verifiable safety and performance endpoints, which are difficult to substantiate retrospectively. Establishing equivalence\u2014particularly for software\u2014often requires deep insight into the core algorithm. Be prepared for a thorough review if you choose this path. <\/p>\n
\n<\/strong> Auditors expect state-of-the-art cybersecurity measures, including vulnerability scans and penetration tests, even if these are not explicitly required. It is advisable to implement these measures proactively. <\/p>\n
\n<\/strong>Usability studies and risk management are of central importance for MDR compliance, even though usability is mentioned in the MDR only in connection with post-market surveillance (PMS). Auditors are increasingly focusing on documentation and traceability and require that all measures\u2014even best practices\u2014be explicitly documented. Keep the original records from your suppliers, as they may be requested during future inspections. <\/p>\n
\n<\/strong>For software, post-market surveillance involves collecting data from support channels, monitoring the Software Bill of Materials (SBOM), reviewing crash reports, and conducting compatibility tests with new operating systems or devices. Changes to SOUP (Software of Unknown Provenance) components or the underlying operating systems occur frequently and require constant vigilance. The more your product gains prominence in the market, the more feedback you can expect, which requires thorough documentation and analysis. <\/p>\nSurvival tips for the MDR landscape<\/h2><\/h2><\/div>
\n<\/strong>Start with a Minimum Viable Product (MVP) to test usability and user acceptance. This approach helps control risks and accelerate progress. <\/p>\n<\/div><\/li>
\n<\/strong>By integrating compliance into agile development cycles, your process remains adaptable while staying in line with MDR requirements.<\/p>\n<\/div><\/li>
\n<\/strong>Think of documentation as your bike. It records every step and ensures you have evidence to present when auditors inquire about your process. <\/p>\n<\/div><\/li>
\n<\/strong>Involve the Notified Bodies, cybersecurity experts, and other stakeholders early on to effectively manage the complexity.<\/p>\n<\/div><\/li><\/ul><\/div><\/div><\/div><\/div>
![](\"https:\/\/www.bayoosoft.com\/wp-content\/uploads\/sites\/5\/2025\/01\/cropped-Orange-yellow-minimalist-lightbulb-logo.png\" "\\"cropped-Orange-yellow-minimalist-lightbulb-logo.png\\""){kind=logo}
<\/span><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":40,"featured_media":9355,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[45,39,47],"tags":[104,110,78],"job-standort":[],"job-bereich":[],"job-arbeitszeit":[],"job-gmbh":[],"class_list":["post-9353","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-bayoosoft-access-manager-en","category-bayoosoft-themis-en","category-posts","tag-access-manager","tag-bayoosoft-themis","tag-mdr-en"],"yoast_head":"\n